This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Add Voya Financial to Your Portfolio
by Zacks Equity Research
Voya Financial (VOYA) rides on operational excellence and promises better rewards for investors.
Top Ranked Value Stocks to Buy for April 4th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 4th
AXIS Capital's (AXS) Strong Premiums Sustain Growth Momentum
by Zacks Equity Research
AXIS Capital (AXS) consistently gains from robust premiums, an expanding portfolio mix, better investment results and a firm capital position.
Athene Holding's Scalable Platform Aids, High Costs Hurt
by Zacks Equity Research
Highly scalable platform, strategic inorganic capabilities and a solid capital position aid Athene Holding (ATH) to retain investor confidence in the stock. But rising expenses remain a dampener.
Implied Volatility Surging for Health Insurance Innovations (HIIQ) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Health Insurance Innovations (HIIQ) stock based on the movements in the options market lately.
Is Health Insurance Innovations (HIIQ) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Health Insurance Innovations (HIIQ) could produce exceptional returns because of its solid growth attributes.
Health Insurance Innovations (HIIQ) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Health Insurance Innovations (HIIQ) closed at $27.84 in the latest trading session, marking a +1.42% move from the prior day.
Here's Why You Should Add Manulife Stock to Your Portfolio
by Zacks Equity Research
Manulife Financial (MFC) rides on operational excellence and promises better rewards for investors.
Life Insurance Stock Outlook: Near-Term Prospects Bright
by Tanuka De
Better rate environment and adoption of technology in daily operations bode well for Life Insurance industry.
Robust Portfolio Aids Intercontinental Despite Rising Costs
by Zacks Equity Research
Intercontinental Exchange (ICE) is poised to grow on compelling product portfolio, acquisitions and effective capital deployment. However, escalating expenses concern.
3 Top Stocks With Upgraded Broker Ratings to Buy Right Away
by Zacks Equity Research
One can follow rating upgrades by brokers as they have a deeper understanding of stocks, the industries and the overall economy.
Primerica Rises 27% in a Year: Can the Bull Run Continue?
by Zacks Equity Research
Shares of Primerica (PRI) is expected to continue the bull run, backed by solid fundamentals and initiatives to ramp up growth.
Health Insurance Innovations (HIIQ) Looks Good: Stock Adds 5.5% in Session
by Zacks Equity Research
Health Insurance Innovations (HIIQ) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Abercrombie and Fitch, Cars.com, Health Insurance Innovations, Aflac and Torchmark highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Abercrombie and Fitch, Cars.com, Health Insurance Innovations, Aflac and Torchmark highlighted as Zacks Bull and Bear of the Day
Health Insurance Up 24% in a Year: Will the Rally Continue?
by Zacks Equity Research
Health Insurance Innovations' (HIIQ) solid fundamentals and favorable industry trends should help the stock continue the bull run.
AM Best Revises Donegal Group (DGICA) and Unit's Outlook
by Zacks Equity Research
Donegal Group (DGICA) and arm receive rating affirmations from credit rating giant AM Best, which in turn, buoys investor hopes on the stock. However, the outlook gets revised from stable to negative.
Here is Why Growth Investors Should Buy Health Insurance Innovations (HIIQ) Now
by Zacks Equity Research
Health Insurance Innovations (HIIQ) is well positioned to outperform the market, as it exhibits above-average growth in financials.
New Strong Buy Stocks for March 12th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Do Options Traders Know Something About Health Insurance Innovations (HIIQ) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Health Insurance Innovations (HIIQ) stock based on the movements in the options market lately.
Health Insurance Innovations (HIIQ) Earnings Expected to Grow: What to Know Ahead of Q4 Release
by Zacks Equity Research
Health Insurance Innovations (HIIQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Options Traders Expect Huge Moves in Health Insurance Innovations (HIIQ) Stock
by Zacks Equity Research
Investors need to pay close attention to Health Insurance Innovations (HIIQ) stock based on the movements in the options market lately.
Moving Average Crossover Alert: Health Insurance Innovations
by Zacks Equity Research
Health Insurance Innovations, Inc. (HIIQ) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
New Strong Sell Stocks for December 28th
by Zacks Equity Research
Here are 3 stocks added to the Zacks Rank #5 (Strong Sell) List today
Health Insurance Innovations (HIIQ) Jumps: Stock Rises 5.2%
by Zacks Equity Research
Health Insurance Innovations (HIIQ) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Options Traders Expect Huge Moves in Health Insurance (HIIQ) Stock
by Zacks Equity Research
Health Insurance (HIIQ) needs investors to pay close attention to the stock based on moves in the options market lately.